1
|
Liu S, Yu M, Luo XY, Liu J, Zou ZM. One-Pot Construction of NHS-Activated Magnetic Particles for Chemoselective Capture of Carboxyl Metabolites. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2025; 12:e2413830. [PMID: 39932453 PMCID: PMC11967832 DOI: 10.1002/advs.202413830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Revised: 01/17/2025] [Indexed: 04/05/2025]
Abstract
Chemoselective probes immobilize on magnetic materials show great promise in simplifying sample handling and enhancing detection sensitivity. However, their complicated preparation and associated expense limit broader application. In this study, novel magnetic particles with abundant N-hydroxysuccinimide (NHS) esters on the surface are conveniently synthesized using a one-pot method without carbodiimide activation carboxylate molecules. Subsequently, multifunctional probes are synthesized by immobilizing high-density chemical probes on the surface of the magnetic materials through a postsynthetic modification strategy. This versatile probe facilitates the rapid capture of carboxylated compounds from complex matrices, with the labeled metabolites release from the magnetic materials subsequently analyzed using ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS). The advantages of this innovative chemical biological tool include the simplicity and low cost of the synthesis, as well as the capability to analyze polar and volatile carboxylated metabolites via LC-MS. This new strategy is successfully applied to analyze short-chain fatty acids (SCFAs) in rat cecal contents, demonstrating the reliability of the analytical method. This study presents a cost-effective and easy-to-implement approach for preparing NHS-activated magnetic particles and offers a versatile probe with chemoselective extraction and labeling capabilities, providing a practical tool for analyzing SCFAs in the gut.
Collapse
Affiliation(s)
- Shuai Liu
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China
| | - Meng Yu
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China
| | - Xin-Yao Luo
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China
| | - Jie Liu
- Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China
| | - Zhong-Mei Zou
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China
| |
Collapse
|
2
|
Minbay MO, Sun R, Ramachandran V, Ay A, Kahveci T. OLTA: Optimizing bait seLection for TArgeted sequencing. Bioinformatics 2025; 41:btaf146. [PMID: 40175314 PMCID: PMC12033030 DOI: 10.1093/bioinformatics/btaf146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 03/17/2025] [Accepted: 03/31/2025] [Indexed: 04/04/2025] Open
Abstract
MOTIVATION Targeted enrichment via capture probes, also known as baits, is a promising complementary procedure for next-generation sequencing methods. This technique uses short biotinylated oligonucleotide probes that hybridize with complementary genetic material in a sample. Following hybridization, the target fragments can be easily isolated and processed with minimal contamination from irrelevant material. Designing an efficient set of baits for a set of target sequences, however, is an NP-hard problem. RESULTS We develop a novel heuristic algorithm that leverages the similarities between the characteristics of the Minimum Bait Cover and the Closest String problems to reduce the number of baits to cover a given target sequence. Our results on real and synthetic datasets demonstrate that our algorithm, OLTA produces fewest baits for nearly all experimental settings and datasets. On average, it produces 6% and 11% fewer baits than the next best state-of-the-art methods for two major real datasets, AIV and MEGARES. Also, its bait set has the highest utilization and the minimum redundancy. AVAILABILITY AND IMPLEMENTATION Our algorithm is available at github.com/FuelTheBurn/OLTA-Optimizing-bait-seLection-for-TArgeted-sequencing. Test data and other software are archived at doi.org/10.5281/zenodo.15086636.
Collapse
Affiliation(s)
- Mete Orhun Minbay
- Department of Computer Science, Colgate University, Hamilton, NY 13346, United States
| | - Richard Sun
- Computer and Information Science and Engineering Department, University of Florida, Gainesville, FL 32611, United States
| | - Vijay Ramachandran
- Department of Computer Science, Colgate University, Hamilton, NY 13346, United States
| | - Ahmet Ay
- Departments of Biology and Mathematics, Colgate University, Hamilton, NY 13346, United States
| | - Tamer Kahveci
- Computer and Information Science and Engineering Department, University of Florida, Gainesville, FL 32611, United States
| |
Collapse
|
3
|
Mao W, Wang J, Li T, Wu J, Wang J, Wen S, Huang J, Shi Y, Zheng K, Zhai Y, Li X, Long Y, Lu J, Guo C. Hybrid Capture-Based Sequencing Enables Highly Sensitive Zoonotic Virus Detection Within the One Health Framework. Pathogens 2025; 14:264. [PMID: 40137749 PMCID: PMC11944581 DOI: 10.3390/pathogens14030264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2025] [Revised: 02/13/2025] [Accepted: 03/03/2025] [Indexed: 03/29/2025] Open
Abstract
Hybrid capture-based target enrichment prior to sequencing has been shown to significantly improve the sensitivity of detection for genetic regions of interest. In the context of One Health relevant pathogen detection, we present a hybrid capture-based sequencing method that employs an optimized probe set consisting of 149,990 probes, targeting 663 viruses associated with humans and animals. The detection performance was initially assessed using viral reference materials in a background of human nucleic acids. Compared to standard metagenomic next-generation sequencing (mNGS), our method achieved substantial read enrichment, with increases ranging from 143- to 1126-fold, and enhanced detection sensitivity by lowering the limit of detection (LoD) from 103-104 copies to as few as 10 copies based on whole genomes. This method was further validated using infectious samples from both animals and humans, including bovine rectal swabs and throat swabs from SARS-CoV-2 patients across various concentration gradients. In both sample types, our hybrid capture-based sequencing method exhibited heightened sensitivity, increased viral genome coverage, and more comprehensive viral identification and characterization. Our method bridges a critical divide between diagnostic detection and genomic surveillance. These findings illustrate that our hybrid capture-based sequencing method can effectively enhance sensitivity to as few as 10 viral copies and genome coverage to >99% in medium-to-high viral loads. This dual capability is particularly impactful for emerging pathogens like SARS-CoV-2, where early detection and genomic characterization are equally vital, thereby addressing the limitations of metagenomics in the surveillance of emerging infectious diseases in complex samples.
Collapse
Affiliation(s)
- Weiya Mao
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Jin Wang
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Ting Li
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325000, China;
| | - Jiani Wu
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Jiangrong Wang
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Shubo Wen
- College of Animal Science and Technology, Inner Mongolia Minzu University, Tongliao 028000, China;
| | - Jicheng Huang
- Guangzhou Customs District Technology Center, Guangzhou 510623, China; (J.H.); (Y.S.); (K.Z.)
| | - Yongxia Shi
- Guangzhou Customs District Technology Center, Guangzhou 510623, China; (J.H.); (Y.S.); (K.Z.)
| | - Kui Zheng
- Guangzhou Customs District Technology Center, Guangzhou 510623, China; (J.H.); (Y.S.); (K.Z.)
| | - Yali Zhai
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Xiaokang Li
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Yan Long
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
| | - Jiahai Lu
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325000, China;
- National Medical Products Administration Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou 510080, China
- One Health Research Center, Hainan Medical University, Haikou 571199, China
- Research Institute of Sun Yat-Sen University in Shenzhen, Shenzhen 518057, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou 510080, China
- One Health Research Center, Baotou Medical College, Baotou 014040, China
- One Health Research Center, Wenzhou Medical University, Wenzhou 325000, China
| | - Cheng Guo
- School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; (W.M.); (J.W.); (J.W.); (J.W.); (Y.Z.); (X.L.); (Y.L.)
- National Medical Products Administration Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou 510080, China
| |
Collapse
|
4
|
Quek ZBR, Ng SH. Hybrid-Capture Target Enrichment in Human Pathogens: Identification, Evolution, Biosurveillance, and Genomic Epidemiology. Pathogens 2024; 13:275. [PMID: 38668230 PMCID: PMC11054155 DOI: 10.3390/pathogens13040275] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 03/11/2024] [Accepted: 03/18/2024] [Indexed: 04/29/2024] Open
Abstract
High-throughput sequencing (HTS) has revolutionised the field of pathogen genomics, enabling the direct recovery of pathogen genomes from clinical and environmental samples. However, pathogen nucleic acids are often overwhelmed by those of the host, requiring deep metagenomic sequencing to recover sufficient sequences for downstream analyses (e.g., identification and genome characterisation). To circumvent this, hybrid-capture target enrichment (HC) is able to enrich pathogen nucleic acids across multiple scales of divergences and taxa, depending on the panel used. In this review, we outline the applications of HC in human pathogens-bacteria, fungi, parasites and viruses-including identification, genomic epidemiology, antimicrobial resistance genotyping, and evolution. Importantly, we explored the applicability of HC to clinical metagenomics, which ultimately requires more work before it is a reliable and accurate tool for clinical diagnosis. Relatedly, the utility of HC was exemplified by COVID-19, which was used as a case study to illustrate the maturity of HC for recovering pathogen sequences. As we unravel the origins of COVID-19, zoonoses remain more relevant than ever. Therefore, the role of HC in biosurveillance studies is also highlighted in this review, which is critical in preparing us for the next pandemic. We also found that while HC is a popular tool to study viruses, it remains underutilised in parasites and fungi and, to a lesser extent, bacteria. Finally, weevaluated the future of HC with respect to bait design in the eukaryotic groups and the prospect of combining HC with long-read HTS.
Collapse
Affiliation(s)
- Z. B. Randolph Quek
- Defence Medical & Environmental Research Institute, DSO National Laboratories, Singapore 117510, Singapore
| | | |
Collapse
|
5
|
Andrew CL, Russell SL, Coombe M, Zlosnik JEA, Kuchinski KS, Caleta J, Fjell C, Berhane Y, Bowes V, Redford T, Thacker C, Wilson L, Henaff M, Harms NJ, Jassem A, Giacinti J, Soos C, Prystajecky N, Himsworth C. Descriptive Epidemiology and Phylodynamics of the "First Wave" of an Outbreak of Highly Pathogenic Avian Influenza (H5N1 Clade 2.3.4.4b) in British Columbia and the Yukon, Canada, April to September 2022. Transbound Emerg Dis 2024; 2024:2327939. [PMID: 40303032 PMCID: PMC12017231 DOI: 10.1155/2024/2327939] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 01/18/2024] [Accepted: 02/01/2024] [Indexed: 05/02/2025]
Abstract
Highly pathogenic avian influenza (HPAI) is a viral disease that causes significant rates of morbidity and mortality in domestic poultry and wild birds, with occasional spillover into mammals, including humans. Beginning in November 2021, Canada experienced its longest and largest outbreak of HPAI in history. A portion of this outbreak (H5N1, clade 2.3.4.4b) occurred in western Canada, specifically in British Columbia (B.C.) and the Yukon, between April 12 and September 11, 2022, which was classified as the "first wave" in this region. Wild birds and mammals identified through passive surveillance and suspect domestic poultry flocks were screened for avian influenza virus (AIV), typed H5 by qPCR, and positive cases were whole genome sequenced. Descriptive epidemiological and phylodynamic analyses were performed to: (1) understand the taxonomic and geographic extent of wild species involved; and (2) examine the origins and probable transmission networks of HPAI viruses introduced into B.C./Yukon by comparing local viruses with those circulating elsewhere in North America. This outbreak included 21 species of wild birds, 2 species of wild mammals, 4 commercial, and 12 domestic small flock infected premises. Canada geese (Branta canadensis) and bald eagles (Haliaeetus leucocephalus) were the most common wild species detected. We demonstrate that north-south avian migration via the Pacific Flyway is the probable route of multiple incursions into this region. Phylogenetic analysis of the hemagglutinin (HA) segment revealed that the B.C./Yukon viruses detected formed five distinct genetic clusters which were maintained across the whole genome. Although, the genome segments were predominantly Eurasian in origin, NP and PB2 segments from all samples, as well as NS and PB1 segments from Cluster 3, had North American origins. Overall, we demonstrate the utility of genomic epidemiology to inform HPAI transmission dynamics across Western Canada and discuss potential knowledge gaps that exist in passive surveillance strategies for HPAI.
Collapse
Affiliation(s)
- Cassandra L. Andrew
- Department of Medicine, School of Population and Public Health, University of British Columbia, 2206 East Mall Vancouver, B.C. V6T 1Z3, Vancouver, Canada
| | - Shannon L. Russell
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Michelle Coombe
- Department of Medicine, School of Population and Public Health, University of British Columbia, 2206 East Mall Vancouver, B.C. V6T 1Z3, Vancouver, Canada
- Animal Health Centre, British Columbia Ministry of Agriculture and Food, 1767 Angus Campbell Road, Abbotsford, B.C. V3G 2M3, Canada
| | - James E. A. Zlosnik
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Kevin S. Kuchinski
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Jessica Caleta
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Public Health Agency of Canada (PHAC), National Microbiology Laboratory (NML), 1015 Arlington St., Winnipeg, Manitoba, R3E 3P6, Canada
| | - Chris Fjell
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Yohannes Berhane
- Canadian Food Inspection Agency, National Centre for Foreign Animal Disease, 1015 Arlington Street, Winnipeg MB R3E 3M4, Canada
| | - Victoria Bowes
- Animal Health Centre, British Columbia Ministry of Agriculture and Food, 1767 Angus Campbell Road, Abbotsford, B.C. V3G 2M3, Canada
| | - Tony Redford
- Animal Health Centre, British Columbia Ministry of Agriculture and Food, 1767 Angus Campbell Road, Abbotsford, B.C. V3G 2M3, Canada
| | - Caeley Thacker
- British Columbia Ministry of Forests, P. O. Box 9338 Stn Prov Govt Victoria, Victoria, B.C., V8W 9M3, Canada
| | - Laurie Wilson
- Canadian Wildlife Service, Environment and Climate Change Canada, Pacific Wildlife Research Centre, 5421 Robertson Road, Delta, B.C. V4K 3N2, Canada
| | - Maud Henaff
- Government of Yukon, Department of Environment, Animal Health Unit, 10 Burns Road, Whitehorse YT Y1A 4Y9, Canada
| | - N. Jane Harms
- Government of Yukon, Department of Environment, Animal Health Unit, 10 Burns Road, Whitehorse YT Y1A 4Y9, Canada
| | - Agatha Jassem
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Jolene Giacinti
- Ecotoxicology and Wildlife Health Division, Science and Technology Branch, Environment and Climate Change Canada, 115 Perimeter Road, Saskatoon, SK S7N 0X4, Canada
| | - Catherine Soos
- Ecotoxicology and Wildlife Health Division, Science and Technology Branch, Environment and Climate Change Canada, 115 Perimeter Road, Saskatoon, SK S7N 0X4, Canada
| | - Natalie Prystajecky
- British Columbia Centre for Disease Control, 655 W 12th Avenue Vancouver, B.C., V5Z 4R4, Vancouver, Canada
- Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, B.C. V6T 1Z7, Canada
| | - Chelsea Himsworth
- Department of Medicine, School of Population and Public Health, University of British Columbia, 2206 East Mall Vancouver, B.C. V6T 1Z3, Vancouver, Canada
- Animal Health Centre, British Columbia Ministry of Agriculture and Food, 1767 Angus Campbell Road, Abbotsford, B.C. V3G 2M3, Canada
- Canadian Wildlife Health Cooperative British Columbia, 1767 Angus Campbell Road, Abbotsford, B.C. V3G 2M3, Canada
| |
Collapse
|
6
|
Kuchinski KS, Coombe M, Mansour SC, Cortez GAP, Kalhor M, Himsworth CG, Prystajecky NA. Targeted genomic sequencing of avian influenza viruses in wetland sediment from wild bird habitats. Appl Environ Microbiol 2024; 90:e0084223. [PMID: 38259077 PMCID: PMC10880596 DOI: 10.1128/aem.00842-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 11/30/2023] [Indexed: 01/24/2024] Open
Abstract
Diverse influenza A viruses (IAVs) circulate in wild birds, including highly pathogenic strains that infect poultry and humans. Consequently, surveillance of IAVs in wild birds is a cornerstone of agricultural biosecurity and pandemic preparedness. Surveillance is traditionally done by testing wild birds directly, but obtaining these specimens is labor intensive, detection rates can be low, and sampling is often biased toward certain avian species. As a result, local incursions of dangerous IAVs are rarely detected before outbreaks begin. Testing environmental specimens from wild bird habitats has been proposed as an alternative surveillance strategy. These specimens are thought to contain diverse IAVs deposited by a broad range of avian hosts, including species that are not typically sampled by surveillance programs. To enable this surveillance strategy, we developed a targeted genomic sequencing method for characterizing IAVs in these challenging environmental specimens. It combines custom hybridization probes, unique molecular index-based library construction, and purpose-built bioinformatic tools, allowing IAV genomic material to be enriched and analyzed with single-fragment resolution. We demonstrated our method on 90 sediment specimens from wetlands around Vancouver, Canada. We recovered 2,312 IAV genome fragments originating from all eight IAV genome segments. Eleven hemagglutinin subtypes and nine neuraminidase subtypes were detected, including H5, the current global surveillance priority. Our results demonstrate that targeted genomic sequencing of environmental specimens from wild bird habitats could become a valuable complement to avian influenza surveillance programs.IMPORTANCEIn this study, we developed genome sequencing tools for characterizing avian influenza viruses in sediment from wild bird habitats. These tools enable an environment-based approach to avian influenza surveillance. This could improve early detection of dangerous strains in local wild birds, allowing poultry producers to better protect their flocks and prevent human exposures to potential pandemic threats. Furthermore, we purposefully developed these methods to contend with viral genomic material that is diluted, fragmented, incomplete, and derived from multiple strains and hosts. These challenges are common to many environmental specimens, making these methods broadly applicable for genomic pathogen surveillance in diverse contexts.
Collapse
Affiliation(s)
- Kevin S Kuchinski
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Michelle Coombe
- Animal Health Centre, Ministry of Agriculture and Food, Abbotsford, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
- Canadian Wildlife Health Cooperative, Abbotsford, British Columbia, Canada
| | - Sarah C Mansour
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Gabrielle Angelo P Cortez
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Marzieh Kalhor
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - Chelsea G Himsworth
- Animal Health Centre, Ministry of Agriculture and Food, Abbotsford, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
- Canadian Wildlife Health Cooperative, Abbotsford, British Columbia, Canada
| | - Natalie A Prystajecky
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- British Columbia Centre for Disease Control, Provincial Health Services Authority, Vancouver, British Columbia, Canada
| |
Collapse
|
7
|
Zufan SE, Mercoulia K, Kwong JC, Judd LM, Howden BP, Seemann T, Stinear TP. High-performance enrichment-based genome sequencing to support the investigation of hepatitis A virus outbreaks. Microbiol Spectr 2024; 12:e0283423. [PMID: 38018979 PMCID: PMC10783085 DOI: 10.1128/spectrum.02834-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 10/14/2023] [Indexed: 11/30/2023] Open
Abstract
IMPORTANCE This proof-of-concept study introduces a hybrid capture oligo panel for whole-genome sequencing of all six human pathogenic hepatitis A virus (HAV) subgenotypes, exhibiting a higher sensitivity than some conventional genotyping assays. The ability of hybrid capture to enrich multiple targets allows for a single, streamlined workflow, thus facilitating the potential harmonization of molecular surveillance of HAV with other enteric viruses. Even challenging sample matrices can be accommodated, making them suitable for broad implementation in clinical and public health laboratories. This innovative approach has significant implications for enhancing multijurisdictional outbreak investigations as well as our understanding of the global diversity and transmission dynamics of HAV.
Collapse
Affiliation(s)
- Sara E. Zufan
- The Center for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Karolina Mercoulia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
- Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Jason C. Kwong
- Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
- Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Louise M. Judd
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
- Doherty Applied Microbial Genomics, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Benjamin P. Howden
- The Center for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
- Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Torsten Seemann
- The Center for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Timothy P. Stinear
- The Center for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| |
Collapse
|
8
|
Kuchinski KS, Loos KD, Suchan DM, Russell JN, Sies AN, Kumakamba C, Muyembe F, Mbala Kingebeni P, Ngay Lukusa I, N’Kawa F, Atibu Losoma J, Makuwa M, Gillis A, LeBreton M, Ayukekbong JA, Lerminiaux NA, Monagin C, Joly DO, Saylors K, Wolfe ND, Rubin EM, Muyembe Tamfum JJ, Prystajecky NA, McIver DJ, Lange CE, Cameron ADS. Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats. eLife 2022; 11:e79777. [PMID: 36346652 PMCID: PMC9643004 DOI: 10.7554/elife.79777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Accepted: 10/18/2022] [Indexed: 11/11/2022] Open
Abstract
Public health emergencies like SARS, MERS, and COVID-19 have prioritized surveillance of zoonotic coronaviruses, resulting in extensive genomic characterization of coronavirus diversity in bats. Sequencing viral genomes directly from animal specimens remains a laboratory challenge, however, and most bat coronaviruses have been characterized solely by PCR amplification of small regions from the best-conserved gene. This has resulted in limited phylogenetic resolution and left viral genetic factors relevant to threat assessment undescribed. In this study, we evaluated whether a technique called hybridization probe capture can achieve more extensive genome recovery from surveillance specimens. Using a custom panel of 20,000 probes, we captured and sequenced coronavirus genomic material in 21 swab specimens collected from bats in the Democratic Republic of the Congo. For 15 of these specimens, probe capture recovered more genome sequence than had been previously generated with standard amplicon sequencing protocols, providing a median 6.1-fold improvement (ranging up to 69.1-fold). Probe capture data also identified five novel alpha- and betacoronaviruses in these specimens, and their full genomes were recovered with additional deep sequencing. Based on these experiences, we discuss how probe capture could be effectively operationalized alongside other sequencing technologies for high-throughput, genomics-based discovery and surveillance of bat coronaviruses.
Collapse
Affiliation(s)
- Kevin S Kuchinski
- Department of Pathology and Laboratory Medicine, University of British ColumbiaVancouverCanada
- Public Health Laboratory, British Columbia Centre for Disease ControlVancouverCanada
| | - Kara D Loos
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| | - Danae M Suchan
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| | - Jennifer N Russell
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| | - Ashton N Sies
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| | | | | | - Placide Mbala Kingebeni
- Metabiota IncKinshasaDemocratic Republic of the Congo
- Institut National de Recherche BiomédicaleKinshasaDemocratic Republic of the Congo
| | | | - Frida N’Kawa
- Metabiota IncKinshasaDemocratic Republic of the Congo
| | | | - Maria Makuwa
- Metabiota IncKinshasaDemocratic Republic of the Congo
- Labyrinth Global Health IncSt. PetersburgUnited States
| | - Amethyst Gillis
- Metabiota IncSan FranciscoUnited States
- Development AlternativesWashingtonUnited States
| | | | | | - Nicole A Lerminiaux
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| | - Corina Monagin
- Metabiota IncSan FranciscoUnited States
- One Health Institute, School of Veterinary Medicine, University of California, DavisDavisUnited States
| | - Damien O Joly
- MetabiotaNanaimoCanada
- Nyati Health ConsultingNanaimoCanada
| | - Karen Saylors
- Labyrinth Global Health IncSt. PetersburgUnited States
- Metabiota IncSan FranciscoUnited States
| | | | | | | | - Natalie A Prystajecky
- Department of Pathology and Laboratory Medicine, University of British ColumbiaVancouverCanada
- Public Health Laboratory, British Columbia Centre for Disease ControlVancouverCanada
| | - David J McIver
- MetabiotaNanaimoCanada
- Institute for Global Health Sciences, University of California, San FranciscoSan FranciscoUnited States
| | - Christian E Lange
- Labyrinth Global Health IncSt. PetersburgUnited States
- MetabiotaNanaimoCanada
| | - Andrew DS Cameron
- Department of Biology, Faculty of Science, University of ReginaReginaCanada
- Institute for Microbial Systems and Society, Faculty of Science, University of ReginaReginaCanada
| |
Collapse
|